Mild cognitive impairment

Handbook of Clinical Neurology - Tập 89 - Trang 217-221 - 2008
Andrew R. Frank1, Ronald C. Petersen1
1Mayo Clinic College of Medicine, Rochester, MN, USA

Tài liệu tham khảo

Arnaiz, 2004, Mild cognitive impairment: a cross‐national comparison, J Neurol Neurosurg Psychiatry, 75, 1275, 10.1136/jnnp.2003.015032 Bell‐McGinty, 2005, Differential cortical atrophy in subgroups of mild cognitive impairment, Arch Neurol, 62, 1393, 10.1001/archneur.62.9.1393 Bennett, 2002, Natural history of mild cognitive impairment in older persons, Neurology, 59, 198, 10.1212/WNL.59.2.198 Chertkow, 2002, Mild cognitive impairment, Curr Opin Neurol, 15, 401, 10.1097/00019052-200208000-00001 Dobert, 2005, Diagnostic value of FDG‐PET and HMPAO‐SPET in patients with mild dementia and mild cognivite impairment: metabolic index and perfusion index, Dement Geriatr Cogn Disord., 20, 63, 10.1159/000085857 Ferris, 2005, Time to clinical diagnosis of dementia in MCI subjects receiving rivastigmine: a randomized, doubl‐blind, placebo‐controlled study, International Psychogeriatrics, 17, 242 Fischer, 2007, Conversion from subtypes of mild cognitive impairment to Alzheimer dementia, Neurology, 68, 288, 10.1212/01.wnl.0000252358.03285.9d Folstein, 1975, “Mini‐mental state” A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6 Hirao, 2005, The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT, Neuroimage, 28, 1014, 10.1016/j.neuroimage.2005.06.066 Jack, 2005, Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI, Neurology, 65, 1227, 10.1212/01.wnl.0000180958.22678.91 Johnson, 2002, Randomized, double‐blind, placebo‐controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report, J Mol Neurosci, 19, 197, 10.1007/s12031-002-0032-4 Kalbe, 2004, Demtect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia, Int J Geriatr Psychiatry, 19, 136, 10.1002/gps.1042 Kokmen, 1991, The short test of mental status. Correlations with standardized psychometric testing, Arch Neurol, 48, 725, 10.1001/archneur.1991.00530190071018 Mayor, 2005, Regulatory authorities review use of galantamine in mild cognitive impairment, BMJ, 330, 276, 10.1136/bmj.330.7486.276-b Meyer, 2002, Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging, J Neurol Sci., 201, 19, 10.1016/S0022-510X(02)00159-4 Nasreddine, 2005, The Montreal Cognitive Assessment, moca: a brief screening tool for mild cognitive impairment, J Am Geriatr Soc., 53, 695, 10.1111/j.1532-5415.2005.53221.x Petersen, 1996, Predictive value of APOE genotyping in incipient Alzheimer's disease, Ann N Y Acad Sci, 802, 58, 10.1111/j.1749-6632.1996.tb32599.x Petersen, 1999, Mild cognitive impairment: clinical characterization and outcome, Arch Neurol, 56, 303, 10.1001/archneur.56.3.303 Petersen, 2001, Practice parameter: early detection of dementia: mild cognitive impairment (an evidence‐based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, 56, 1133, 10.1212/WNL.56.9.1133 Petersen, 2005, Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment, N Engl J Med, 352, 2379, 10.1056/NEJMoa050151 Rasquin, 2005, Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2‐year follow‐up study, Dement Geriatr Cogn Disord., 19, 113, 10.1159/000082662 Thal, 2005, A randomized, double‐blind, study of rofecoxib in patients with mild cognitive impairment, Neuropsychopharmacology, 30, 1204, 10.1038/sj.npp.1300690 Waegemans, 2002, Clinical efficacy of piracetam in cognitive impairment: a meta‐analysis, Dement Geriatr Cogn Disord., 13, 217, 10.1159/000057700 Winblad, 2004, Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment, J Intern Med, 256, 240, 10.1111/j.1365-2796.2004.01380.x